FrancophonIA/ELRC3.0 huggingface dataset:
English: They are marked ‘GSCL5' on one side; and ‘25' on the other.
Maltese: Huma mmarkati ‘GSCL5' fuq naħa waħda; u ‘25' fuq in-naħa l-oħra.
English: Clinical efficacy and safety in children aged 1 to 24 months
Maltese: Effikaċja klinika u sigurta' fit-tfal ta' eta' minn 1 sa 24 xahar
English: Packs of 30, 56 or 100 tablets.
Maltese: Pakketti ta' 30, 56 jew 100 pillola
English: Table 2: Children and adolescents aged 2 to 12 years - recommended treatment regimen in epilepsy (total daily dose in mg/kg body weight/day)
Maltese: Tabella 2: Tfal u adolexxenti ta' minn sentejn sa 12-il sena - programm ta' dożaġġ rakkomandat għal epilessija (doża totali ta' kuljum f'mg/piż tal-ġisem/kuljum
English: **Rash has also been reported as part of a hypersensitivity syndrome associated with a variable pattern of systemic symptoms including fever, lymphadenopathy, facial oedema and abnormalities of the blood and liver.
Maltese: **Raxx ġie rappurtat bħala parti mis-sindrome ta' sensittivita' eċċessiva assoċjata ma' għamla li tvarja ta' sintomi sistemiċi inklużi deni, limfadenopatija, edema fil-wiċċ, u anormalitajiet fid-demm u fil-fwied.
English: Evidence from in vitro studies indicates that lamotrigine does not displace other AEDs from protein binding sites.
Maltese: Evidenza minn studji in vitro tindika li lamotrigine ma jieħux post AEDs oħra f'siti li jwaħħlu l-proteini.
English: headache.
Maltese: Csorsz u.
English: Apart from the indication in bipolar disorder the SPC of Lamictal in the different EU members show a large overlap.
Maltese: Minbarra l-indikazzjoni fid-disturb bipolari l-SPC ta' Lamictal fil-membri differenti ta' l-UE juru ħafna aspetti komuni.
English: Gastrointestinal disorders During monotherapy clinical trials:
Maltese: Waqt provi kliniċi b'monoterapija:
English: 50 mg Tablet
Maltese: 50 mg Pillola
English: Each Lamictal 25 mg tablet contains 25 mg lamotrigine.
Maltese: Kull pillola Lamictal 25 mg fiha 25 mg lamotrigine.
English: Valproate, which inhibits the glucuronidation of lamotrigine, reduces the metabolism of lamotrigine and increases the mean half-life of lamotrigine nearly two-fold.
Maltese: Valproate, li hu impeditur tal-glukuronidazzjoni ta' lamotrigine, inaqqas il-metaboliżmu ta' lamotrigine u jżid il-medja tal-half-life ta' lamotrigine kważi bid-doppju.
English: The CHMP was of the opinion that lamotrigine is effective in preventing one aspect of mood episodes in Bipolar disorder, depressive episodes, while prevention of manic or hypomanic episodes has not been proven.
Maltese: Is-CHMP kien tal-fehma li lamotriġina hija effikaċi fil-prevenzjoni ta' aspett wieħed biss ta' l-episodji talburdata fid-disturb bipolari, episodji depressivi, filwaqt li l-prevenzjoni ta' episodji ta' manija jew ta' ipomanija ma ġewx ippruvati.
English: Withdrawal of valproate (inhibitor of lamotrigine glucuronidation - see section 4.5), depending on original dose of lamotrigine:
Maltese: Żjieda ta' valproate (impeditur ta' glukuronidazzjoni ta' lamotrigine - ara sezzjoni 4.5), skond id-doża oriġinali ta' lamotrigine:
English: Week 1 (beginning with withdrawal)
Maltese: Ġimgħa 1 (tibda malli jitwaqqaf
English: During the pill-free week, a two-fold increase in lamotrigine levels has been observed.
Maltese: Matul ilġimgħa bla pilloli, ġiet osservata żjieda doppja fil-livelli ta' lamotrigine.
English: Starter pack of 21 or 42 tablets.
Maltese: Pakkett ta' 21 jew 42 pilloli biex tibda bih.
English: Each Lamictal 50 mg tablet contains 50 mg lamotrigine.
Maltese: Kull pillola Lamictal 50 mg fiha 50 mg lamotrigine.
English: GlaxoSmithKline Oy Piispansilta 9 A 02230 Espoo Finland
Maltese: Finlandja GlaxoSmithKline Oy Piispansilta 9 A
English: nystagmus.
Maltese: nistagmus
English: 100 mg Tablet
Maltese: 100 mg Pillola
English: Lamictal 200 mg disperzibilne/žvečljive tablete 200 mg Dispersible/Chewable Tablet
Maltese: Lamictal 200 mg disperzibilne/žvečljive tablete 200 mg Pillola li tinxtered / li tomgħodha
English: Study SCAB2006 had a similar design as study SCAB2003, but differed from study SCAB2003 in evaluating a flexible dose of lamotrigine (100 to 400 mg/day) and including patients with bipolar I disorder who had recently or were currently experiencing a manic episode.
Maltese: SCAB2006 kellu pjan simili bħal l-istudju SCAB2003, imma kien differenti mill-istudju SCAB2003 flevalwazzjoni ta' doża flessibli ta' lamotrigine (minn 100 sa 400mg/kuljum) u kien jinkludi pazjenti b'disturb bi-polari I li kellhom riċentement jew kienu qegħdin jesperjenzaw episodju ta' mania.
English: Packs of 14, 30, 42, 56, 90 or 100 tablets.
Maltese: Pakketti ta' 14, 30, 42, 56, 90 jew 100 pillola.
English: There are limited data on the efficacy and safety of lamotrigine for adjunctive therapy of partial seizures in children aged 1 month to 2 years (see section 4.4).
Maltese: Hemm tagħrif limitat dwar l-effikaċja u s-sigurta' ta' lamotrigine bħala terapija addizjonali ta' aċċessjonijiet parzjali fi tfal ta' eta minn xahar sa sentejn (ara s-sezzjoni 4.4).
English: The pharmacokinetics of lamotrigine are linear up to 450 mg, the highest single dose tested.
Maltese: Il-farmakokinetiċi ta' lamotrigine huma lineari sa 450 mg, l-ogħla doża waħedha li ġiet ittestjata.
English: Table 4: Adults aged 18 years and above - maintenance stabilisation total daily dose following withdrawal of concomitant medicinal products in treatment of bipolar disorder Once the target daily maintenance stabilisation dose has been achieved, other medicinal products may be withdrawn as shown below.
Maltese: Tabella 4: Adulti ta' minn 18-il sena 'l fuq - doża totali ta' kuljum rakkomandata biex tinkiseb stabbilizzazzjoni wara li jitwaqqfu mediċini konkomitanti fit-trattament ta' mard bi-polari.
English: Pale, yellowish-brown, multifaceted, super-elliptical tablet, marked “GSEE7” on one side and “200” on the other.
Maltese: Ta' kulur isfar-kannella mitfi, b'numru ta' faċċati, super-ellittiċi, immarkati “GSEE7” fuq naħa u “200” fuq l-oħra.
English: Clinical worsening and suicide risk
Maltese: Sitwazzjoni klinika li tmur għall-agħar u riskju ta' suwiċidju
English: An effect of this magnitude is not generally expected to be clinically relevant.
Maltese: Effett ta' dan il-kobor mhuwiex ġeneralment mistenni li jkun ta' rilevanza klinika.
English: The rash, usually maculopapular in appearance, generally appears within eight weeks of starting treatment and resolves on withdrawal of Lamictal (see section 4.4).
Maltese: Ir-raxx, li normalment ikun jidher ta' għamla makulopapulari, ġeneralment jitfaċċa matul l-ewwel tmien ġimgħat minn mindu jinbeda t-trattament u jgħaddi malli Lamictal jitwaqqaf (ara sezzjoni 4.4).
English: Lamotrigine has a slight inhibitory effect on dihydrofolic acid reductase and could therefore theoretically lead to an increased risk of embryofoetal damage by reducing folic acid levels (see section 4.4).
Maltese: Lamotrigine għandu ftit effett ta' impeditur fuq dihydrofolic acid reductase u għalhekk jista' teoretikament iwassal għal riskju akbar ta' ħsara għall-fetu embrijoniku billi jnaqqas il-livelli ta' aċidu foliku (ara sezzjoni 4.4).
English: Administration of lamotrigine resulted in a 15% increase in topiramate concentrations.
Maltese: L-għoti ta' lamotrigine irriżulta f'żjieda ta' 15% fil-konċentrazzjonijiet ta' topiramate.
English: Overdose has resulted in symptoms including nystagmus, ataxia, impaired consciousness and coma.
Maltese: Teħid ta' doża eċċessiva rriżultat f'sintomi bħal nistagmus, ataksija, disturbi tas-sensi u koma.
English: These effects were observed at the expected clinical exposure.
Maltese: Dawn l-effetti ġew osservati f'esponiment kliniku kif mistenni.
English: These have included potentially life-threatening rashes such as Stevens-Johnson syndrome and toxic epidermal necrolysis (see section 4.8).
Maltese: Ma' dawn kien hemm każijiet ta' raxx li jista' jipperikola l-ħajja bħas-sindrome Stevens-Johnson u nekroliżi tossika tal-ġilda (ara sezzjoni 4.8).
English: In addition, a study of bufuralol metabolism using human liver microsome preparations suggested that lamotrigine would not reduce the clearance of medicinal products metabolised predominantly by CYP2D6.
Maltese: Barra dan, studju dwar ilmetaboliżmu ta' bufuralol bl-użu ta' preparamenti ta' mikrosomi tal-fwied uman indikaw li lamotrigine ma jnaqqasx mit-tneħħija ta' prodotti mediċinali metabolizzati prinċipalment b'CYP2D6.
English: There are no pharmacokinetic interactions between lamotrigine and pregabalin.
Maltese: Ma hemmx problemi ta' interazzjoni fil-farmakokinetiċi ta' bejn lamotrigine u pregabalin.
English: Following the co-administration of risperidone 2 mg with lamotrigine, 12 out of the 14 volunteers reported somnolence compared to 1 out of 20 when risperidone was given alone, and none when lamotrigine was administered alone.
Maltese: Wara li ħadu 2 mg risperidone flimkien ma' lamotrigine, 12 mill-14 voluntieri rrappurtaw ħedla ta' rqad meta mqabbla ma' 1 minn 20 li ngħataw risperidone waħdu, u ħadd minnhom meta lamotrigine ingħata waħdu.
English: 5 mg dispersible/chewable tablets - where 2 mg dispersible/chewable tablets are not marketed and Lamictal 5 mg dispersible/chewable tablets are the lowest marketed strength: <* If the calculated daily dose in patients taking valproate is 2.5 mg or more but less than 5 mg, then Lamictal 5 mg dispersible/chewable tablets may be taken on alternate days for the first two weeks.
Maltese: Pilloli li jixterdu/jiġu mimgħuda ta' 5 mg - meta pilloli ta' 2 mg li jixterdu/jiġu mimgħuda ma jkunux fissuq u pilloli Lamictal ta' 5 mg li jistgħu jixterdu /jiġu mimgħuda huma l-inqas qawwija fis-suq: <*Jekk id-doża kalkolata għal kuljum f'pazjenti fuq il-valproate hi 2.5 mg jew aktar iżda inqas minn 5 mg, hemmhekk pilloli Lamictal ta' 5 mg li jixterdu/jiġu mimgħuda jistgħu jittieħdu darba iva u oħra le għallewwel ġimgħatejn.
English: Medicinal products that significantly induce glucuronidation of lamotrigine
Maltese: Prodotti mediċinali li huma indutturi sinifikanti talglukuronidazzjoni ta' lamotrigine
English: Musculoskeletal and connective tissue disorders During bipolar disorder clinical trials: Common:
Maltese: Disturbi muskulo-skeletriċi u tal-connective tissue Waqt provi kliniċi dwar mard bi-polari:
English: Consideration should be given to changing the therapeutic regimen, including possibly discontinuing the medication, in patients who experience clinical worsening (including development of new symptoms) and/or the emergence of suicidal ideation/behaviour, especially if these symptoms are severe, abrupt in onset, or were not part of the patient's presenting symptoms.
Maltese: Għandha tingħata konsiderazzjoni li tindbidel is-sistema ta' kura, kif ukoll il-possibilita' li titwaqqaf ilmediċina, f'pazjenti li jesperjenzaw sitwazzjoni klinika li tmur għall-agħar, (li tinkludi żvilupp ta' sintomi ġodda) u/jew l-emerġenza ta' ideazzjoni/aġir ta' suwiċidju, speċjalment jekk dawn is-sintomi ikunu severi, jidhru f'daqqa, jew ma jkunux parti mis-sintomi li jippreżenta bihom il-pazjent.
English: 5 − 15 mg/kg/day (once a day or two divided doses)
Maltese: 5 − 15 mg/kg/kuljum (darba kuljum jew żewġ dożi maqsuma)
English: 6.5 Nature and contents of container 25 mg tablets:
Maltese: In-natura tal-kontenitur u ta' dak li hemm ġo fih Pilloli ta' 25 mg:
English: Lamictal 100 mg disperzibilne/žvečljive tablete 100 mg Dispersible/Chewable Tablet
Maltese: Lamictal 100 mg disperzibilne/žvečljive tablete 100 mg Pillola li tinxtered / li tomgħodha
English: Lamictal treats epilepsy by blocking the signals in the brain that trigger epileptic seizures (fits).
Maltese: M'għandekx twaqqaf it-trattament kontra l-epilessija meta tkun tqila.
English: Lamictal Dispersible 25mg Starter-Pack Add-on 25 mg Dispersible Tablet
Maltese: Lamictal Dispersible 25mg Starter-Pack Add-on 25 mg Pillola li tinxtered Jittieħed millħalq
English: In reproductive and developmental toxicity studies in rodents and rabbits, no teratogenic effects but reduced foetal weight and retarded skeletal ossification were observed, at exposure levels below or similar to the expected clinical exposure.
Maltese: Fi studji dwar tossiċita' riproduttiva u dik ta' żvilupp fi ġrieden u fniek, ebda effetti teratoġeniċi ma ġew osservati ħlief tnaqqis ta' piż tal-fetu u ossifikazzjoni skeletrika ritardjata, f'livelli ta' esponiment inqas jew simili għal dawk mistennija f'esponiment kliniku.
English: “Children 2 to 12 years {Tradename} is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures including tonic-clonic seizures and the seizures associated with Lennox-Gastaut Syndrome”.
Maltese: "Tfal ta' bejn sentejn u 12-il sena {Isem kummerċjali} huwa indikat bħala terapija aġġuntiva fit-trattament ta' l-epilessija, għal kriżijiet parzjali u ġeneralizzati inklużi l-kriżijiet toniko-kloniċi u l-kriżijiet assoċjati mas-Sindromu Lennox-Gastaut".
English: Lamictal Dispersible 50mg Starter-Pack add-on 50 mg Dispersible Tablet
Maltese: Lamictal Dispersible 50mg Starter-Pack add-on 50 mg Pillola li tinxtered Jittieħed millħalq
English: The IC50 was approximately nine-times above the maximum therapeutic free concentration.
Maltese: L-IC50 kien madwar disgħa darbiet aktar 'il fuq mill-konċentrazzjoni massima bla terapija.
English: When concomitant AEDs are withdrawn or other AEDs/medicinal products are added on to treatment regimes containing lamotrigine, consideration should be given to the effect this may have on lamotrigine pharmacokinetics (see section 4.5).
Maltese: Meta xi AEDs oħra li jkunu qed jittieħdu flimkien jitwaqqfu jew meta xi AEDs/prodotti mediċinali oħra jiżdiedu ma' trattamenti li jkun fihom lamotrigine, għandu jiġi meqjus x'effett dan jista' jkollu fuq ilfarmakokinetiċi ta' lamotrigine (ara sezzjoni 4.5).
English: Lamictal 50 mg tablets are marked ‘GSEE1' on one side and ‘50' on the other.
Maltese: Il-pilloli Lamictal tal-50 mg huma mmarkati ‘GSEE1' fuq naħa u ‘50' fuq l-oħra.
English: There have been reports of decreased lamotrigine plasma levels during pregnancy with a potential risk of loss of seizure control.
Maltese: Ġie rappurtat tnaqqis fil-livelli ta' plasma fil-lamotrigine waqt it-tqala bil-possibilta' ta' riskju ta' telf ta' kontroll waqt xi attakk.
English: nausea, vomiting.
Maltese: aġitazzjoni, nagħas, sturdamenti.
English: 150 mg/day Maintain this dose (150 mg/day)
Maltese: Żomm din id-doża (150 mg/kuljum)
English: Packs of 10, 14, 30, 42, 50, 56, 60, 90, 100 or 200 dispersible/chewable tablets.
Maltese: Pakketti ta' 10, 14, 30, 42, 50, 56, 60, 90, 100 jew 200 jixterdu/jiġu mimgħuda.
English: Only about 2% of lamotrigine-related material is excreted in faeces.
Maltese: Madwar 2% biss ta' materjal relatat ma' lamotrigine jitneħħa mal-ħmieġ.
English: Mean half-life is reduced to approximately 14 hours when given with glucuronidation-inducing medicinal products such as carbamazepine and phenytoin and is increased to a mean of approximately 70 hours when co-administered with valproate alone (see section 4.2).
Maltese: Ilmedja tal-half-life titnaqqas b'madwar 14-il siegħa meta jingħata ma' prodotti mediċinali li jinduċu lglukuronidazzjoni bħal m'huma carbamazepine u phenytoin u tiżdied għal medja ta' madwar 70 siegħa meta mogħti flimkien ma' valproate waħdu (ara sezzjoni 4.2).
English: Lamictal 25 mg tablets are marked ‘GSEC7' on one side and ‘25' on the other.
Maltese: Il-pilloli Lamictal tal-25 mg huma mmarkati ‘GSEC7' fuq naħa u ‘25' fuq l-oħra.
English: 10 dispersible/chewable tablets 30 dispersible/chewable tablets 50 dispersible/chewable tablets 56 dispersible/chewable tablets 60 dispersible/chewable tablets 90 dispersible/chewable tablets 100 dispersible/chewable tablets 200 dispersible/chewable tablets
Maltese: 10 pilloli li jixterdu/jiġu mimgħuda 30 pilloli li jixterdu/jiġu mimgħuda 50 pilloli li jixterdu/jiġu mimgħuda 56 pilloli li jixterdu/jiġu mimgħuda 60 pilloli li jixterdu/jiġu mimgħuda 90 pilloli li jixterdu/jiġu mimgħuda 100 pilloli li jixterdu/jiġu mimgħuda 200 pilloli li jixterdu/jiġu mimgħuda
English: Measurement of serum FSH, LH and oestradiol during the study indicated some loss of suppression of ovarian hormonal activity in some women, although measurement of serum progesterone indicated that there was no hormonal evidence of ovulation in any of the 16 subjects.
Maltese: Il-kejl ta' FSH, LH u oestradiol fis-serum waqt listudju wera xi tnaqqis ta' soppressjoni fl-attivita' ormonali ta' l-ovarju f'xi wħud min-nisa, għalkemm ilkejl ta' progesterone tas-serum indika li ma kien hemm ebda evidenza ormonali ta' ovulazzjoni f'xi waħda mis-16-il mara.
English: Each pack contains blisters of 10, 14, 21, 28, 30, 42, 50, 56 or 60 tablets.
Maltese: Kull pakkett fih strixxi ta' 10, 14, 21, 28, 30, 42, 50, 56 jew 60 pilloli.
English: Each pack contains blisters of 10, 14, 28, 30, 50 or 56 tablets.
Maltese: Kull pakkett fih strixxi ta' 10, 14, 28, 30, 50 jew 56 pilloli.
English: There is considerable inter-individual variation in steady state maximum concentrations but within an individual, concentrations rarely vary.
Maltese: Hemm varjazjoni konsiderevoli bejn individwu u ieħor f'dawk li huma konċentrazzjonijiet massimi steady state, biss konċentrazzjonijiet fl-istess individwu rarament ivarjaw.
English: Lamictal 25 mg disperzibilne/žvečljive tablete 25 mg Dispersible/Chewable Tablet
Maltese: Lamictal 25 mg disperzibilne/žvečljive tablete 25 mg Pillola li tinxtered / li tomgħodha
English: The mean clearance in the elderly (0.39 mL/min/kg) lies within the range of the mean clearance values (0.31 to 0.65 mL/min/kg) obtained in nine studies with non-elderly adults after single doses of 30 to 450 mg.
Maltese: It-tneħħija medja fl-anzjani (0.39 mL/min/kg) qiegħda fl-iskala tal-valuri tal-medja ta' tneħħija (0.31 sa 0.65 mL/min/kg) li ħarġu minn disgħa studji fuq adulti mhux anzjani wara dożi waħedhom ta' 30 sa 450 mg.
English: Lamictal Dispersible 25mg Starter-Pack Mono 25 mg Dispersible Tablet
Maltese: Lamictal Dispersible 25mg Starter-Pack Mono 25 mg Pillola li tinxtered Jittieħed millħalq
English: Children and adolescents aged 2 to 12 years - Adjunctive treatment of partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with Lennox-Gastaut syndrome.
Maltese: Tfal u adolexxenti ta' bejn sentejn u 12-il sena - Trattament aġġuntiv tal-kriżijiet parzjali u tal-kriżijiet ġeneralizzati, inklużi l-kriżjiet toniko-kloniċi u l-kriżijiet assoċjati mas-sindromu ta' Lennox-Gastaut.
English: Lamictal is not recommended for use in children below 18 years of age due to a lack of data on safety and efficacy (see section 4.4).
Maltese: Lamictal mhuwiex rakkomandat għal tfal taħt it-18-il sena minħabba nuqqas ta' tagħrif dwar sigurta' u effikaċja (ara sezzjoni 4.4).
English: Symptoms of these reactions include:
Maltese: Id-Detentur ta' l-Awtorizzazzjoni għat-Tqegħid fis-Suq:
English: Packs of 10, 14, 21, 28, 30, 42, 50, 56 or 60 dispersible/chewable tablets.
Maltese: Pakketti ta' 10, 14, 21, 28, 30, 42, 50, 56 jew 60 pilloli li jixterdu/jiġu mimgħuda.
English: A decrease in lamotrigine levels has been associated with loss of seizure control.
Maltese: Tnaqqis fil-livelli ta' lamotrigine ġie assoċjat ma' tnaqqis ta' kontroll waqt attakk.
English: OTHER
Maltese: Î
English: Nervous system disorders During monotherapy clinical trials: Very common:
Maltese: Disturbi fis-sistema nervuża Matul provi kliniċi b'monoterapija:
English: Lamictal is given as adjunctive therapy but may be the initial antiepileptic drug (AED) to start with in Lennox-Gastaut syndrome.
Maltese: Lamictal jingħata bħala terapija aġġuntiva iżda jista' jkun il-mediċina antiepilettika inizjali (AED) użata għas-sindromu ta' Lennox-Gastaut.
English: Medicinal products that significantly inhibit glucuronidation of lamotrigine
Maltese: Prodotti mediċinali li huma impedituri sinifikanti talglukuronidazzjoni ta' lamotrigine
English: Lamictal 5 mg disperzibilne/žvečljive tablete 5 mg Dispersible/Chewable Tablet
Maltese: Lamictal 5 mg disperzibilne/žvečljive tablete
English: 150 mg/day 225 mg/day 300 mg/day
Maltese: 150 mg/kuljum 150 mg/kul jum225 mg/kulju m
English: Each pack contains blisters of 10, 14, 30, 42, 50, 56, 60, 90, 100 or 200 tablets.
Maltese: Kull pakkett fih strixxi ta' 10, 14, 30, 42, 50, 56, 60, 90, 100 jew 200 pilloli.
English: Thirty-eight responders (> 40% decrease in seizure frequency) were randomised to placebo or continuation of lamotrigine.
Maltese: Tmienja u tletin minn dawk li rrispondew (>40% tnaqqis fil-frekwenza ta' aċċessjonijiet) ġew imqassma bl-addoċċ jew għal plaċebo jew inkella jkomplu fuq lamotrigine.
English: Elderly (above 65 years)
Maltese: Anzjani ('il fuq minn 65 sena)
English: Risk related to antiepileptic drugs in general
Maltese: Riskju li ġeneralment għandu x'jaqsam ma' mediċini anti-epilettiċi
English: 100 mg/day 150 mg/day 200 mg/day
Maltese: 150 mg/kulju m200 mg/kuljum
English: The age range will be modified to reflect the ages for which supporting data are available, adults and patients aged 13 years and older (adolescents).
Maltese: Il-faxxa ta' l-età sejra tiġi modifika biex tirrifletti l-etajiet li għalihom huwa disponibbli tagħrif ta' sostenn, adulti u pazjenti ta' 13-il sena u iktar (adolexxenti).
English: 25 mg/day (once a day)
Maltese: 25 mg/kuljum (darba kuljum)
English: Packs of 10, 30, 50, 56, 60, 90, 100 or 200 dispersible/chewable tablets.
Maltese: Pakketti ta' 10, 30, 50, 56, 60, 90, 100 jew 200 pilloli jixterdu/jiġu mimgħuda.
English: 200 mg/day 150 mg/day 100 mg/day
Maltese: 200 mg/kuljum 100 mg/kulj um
English: 300 mg/day 225 mg/day 150 mg/day
Maltese: 300 mg/kuljum 300 mg/kulju m225 mg/kulju m
English: For adults aged 18 years and over, Lamictal can be used on its own or with other medicines, to prevent the periods of depression that occur in bipolar disorder.
Maltese: F'adulti ta' 18-il sena 'l fuq, Lamictal jista' jintuża waħdu jew ma' mediċini oħra, biex jgħin fil-prevenzjoni ta' perijodi ta' depressjoni li jseħħu f'mard bi-polari.
English: Lamictal 50 mg disperzibilne/žvečljive tablete 50 mg Dispersible/Chewable Tablet
Maltese: Lamictal 50 mg disperzibilne/žvečljive tablete 50 mg Pillola li tinxtered / li tomgħodha
English: Csorsz u. 43.
Maltese: It-tneħħijiet medji kienu 0.
English: 200 mg/day 300 mg/day 400 mg/day
Maltese: 200 mg/kuljum 300 mg/kulju m
English: Whereas
Maltese: Tista'
English: If your seizures happen more often, or if you experience a severe seizure while you're taking Lamictal:
Maltese: Jekk l-aċċessjonijiet tiegħek jiġru aktar spiss, jew jekk tesperjenza aċċessjoni qawwija waqt li tkun tieħu Lamictal:
English: 200 mg/day Maintain this dose (200 mg/day) (two divided doses)
Maltese: Żomm din id-doża (200 mg/kuljum) (żewġ dożi maqsuma)
English: Keep this leaflet.
Maltese: Popolazzjonijiet ta' pazjenti speċjali
English: “Adults and children above 12 years {Tradename} is indicated for use as adjunctive or monotherapy in the treatment of epilepsy, for partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with Lennox-Gastaut Syndrome”.
Maltese: "Adulti u tfal ta' 'l fuq minn 12-il sena {Isem kummerċjali} huwa indikat għall-użu bħala terapija aġġuntiva jew monoterapija fit-trattament ta' lepilessija, għal kriżijiet parzjali u ġeneralizzati, inklużi l-kriżijiet toniko-kloniċi u l-kriżijiet assoċjati masSindromu Lennox-Gastaut".
English: Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.
Maltese: Pazjenti bi problemi ereditarji rari ta' intolleranza ta'galattosju, b'defiċjenza ta' Lapp lactase jew ta' assorbiment ħażin ta' glukosju-galattosju m'għandhomx jieħdu din il-mediċina.
English: The recommended dose escalation and maintenance doses for adults and adolescents aged 13 years and above (Table 1) and for children and adolescents aged 2 to 12 years (Table 2) are given below.
Maltese: Iż-żjieda ta' doża u d-dożi meħtieġa rakkomandati għal adulti u adolexxenti ta' 13-il sena u aktar (Tabella 1) u għal tfal u adolexxenti ta' bejn is-2 u t-12-il sena (Tabella 2) jidhru hawn taħt.